Psych
•
Fri, Nov 24
Short Wave Pharma: innovating eating disorder care with psychedelics
psychedelichealth.co.uk
0
keyboard_arrow_down
Psych
•
Mon, Nov 20
Compass Pathways launches Phase 3 psilocybin trial in UK
psychedelichealth.co.uk
0
Psych
•
Wed, Nov 15
US allocates $2 million for psychedelic research into Substance Use Disorder
psychedelichealth.co.uk
0
Psych
•
Tue, Nov 14
Beyond Psilocybin: the fascinating world of functional mushrooms
psychedelichealth.co.uk
0
Psych
•
Tue, Nov 14
PAREA’s psychedelic push: improving policy for mental health innovation in Europe
psychedelichealth.co.uk
0
Psych
•
Wed, Nov 8
MDMA and psilocybin reach Australia in historic shipment
psychedelichealth.co.uk
0
Psych
•
Mon, Nov 6
Study to investigate psilocybin therapy for cancer-related depression
psychedelichealth.co.uk
0
Psych
•
Fri, Nov 3
Extended DMT administration safe and well tolerated, study shows
psychedelichealth.co.uk
0
Psych
•
Wed, Nov 1
Psilocybin for major depression trial shows positive results
psychedelichealth.co.uk
0
Psych
•
Mon, Oct 30
Oakland ballot seeks to legalise medical psychedelics
psychedelichealth.co.uk
0